GlassScriptPhysician profile
Ellen O Farrell
NPI 1386350171
$3,885.15
in general payments reported to CMS, 2019-2025
20 companies · $776 in 2025
The $776 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $133 · 2024: $2,976 · 2025: $776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,568 · Travel and Lodging: $1,317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,567.71 |
| Travel and Lodging | $1,317.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,859.48 | 2024 | Vns Therapy |
| Neurocrine Biosciences, INC. | $364.27 | 2024-2025 | Ingrezza |
| Alexion Pharmaceuticals, INC. | $347.40 | 2023-2025 | Ultomiris |
| Genentech, INC. | $342.14 | 2024-2025 | Ocrevus |
| Biogen, INC. | $270.73 | 2023-2024 | Vumerity |
| Emd Serono, INC. | $124.14 | 2024 | Mavenclad |
| E.R. Squibb & Sons, L.L.C. | $120.78 | 2025 | Zeposia |
| Acadia Pharmaceuticals INC | $94.09 | 2024 | Nuplazid |
| Abbvie INC. | $87.48 | 2024-2025 | |
| Pfizer INC. | $46.51 | 2024-2025 | |
| Boston Scientific Corporation | $36.25 | 2025 | Ams 700 |
| Axsome Therapeutics, INC. | $35.97 | 2025 | Symbravo |
| Jazz Pharmaceuticals INC. | $28.17 | 2024 | |
| Eisai INC. | $22.04 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.01 | 2024 | Hyqvia |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $19.31 | 2024 | |
| Mdd US Operations, LLC | $18.56 | 2024 | Gocovri |
| Tg Therapeutics, INC. | $17.17 | 2023 | |
| Alnylam Pharmaceuticals INC. | $15.20 | 2023 | Amvuttra |
| Harmony Biosciences LLC | $14.45 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Farrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.